Thematic funds: What is the healthspan and why does it matter for investments in longevity?

The 'healthspan' is currently experiencing heightened public interest: the goal is to spend as much time as possible in good health. The concept is also interesting from an investor's point of view – but its complexity requires expertise to understand.

Diego D'Argenio and Chi Tran-Brändli

Die «Gesundheitsspanne» misst die Zeit, die Menschen bei guter körperlicher und geistiger Verfassung geniessen können (Bildquelle: ZKB).

Those who have decided to have a ‘dry January’ this year are often acting on impulse: the merry excesses of the festive season should be offset by abstinence, at least until the beginning of February. Those who also go out and buy a year's membership to the gym are taking it a step further: they are at least expressing the desire to lead an active and healthy lifestyle – in the hope of not just living better, but also living longer.

The latter may be part of a structural trend that can also be an exciting investment theme: the pursuit of healthy longevity. With the prospect that the world could have more than 2 billion people over the age of 60 by 2050, the megatrend of an ageing population is arguably the largest under-tapped market of all. After all, China has been hyped as major market and investment opportunity over the last two decades, but its population is less than 1.5bn and is expected to shrink over the next decades.

Health lags behind

The ‘healthy’ part of longevity appears to be particularly desirable and promising from an economic point of view. Life expectancy may have increased by three decades since the mid-20th century. However, it appears that health has lagged behind. For example, according to the World Health Organization (WHO) life expectancy. People might live longer, they're often often plagued by chronic illnesses towards the later years in life. In the US, the National Council on Aging calculated that 80% of people over 65 years of age have two or more chronic illnesses.

In this context, the concept of ‘healthspan’ has been thrusted into the limelight. In contrast to lifespan, it measures the time that people can enjoy in good physical and mental health. The focus is on the quality of life. The aim is to extend this as much as possible: ‘squaring the healthspan curve’ is the name of the game here, i.e. extending the healthspan curve at the as far out as possible towards the end of life (see table below). Author Peter Attia, who has contributed to popularize the subject, puts it this way: ‘You want to skate smoothly to the very end of your life, not hobble to the finish line.’

Quest for an extension of healthspan

Sources: ZKB / 'Phytonutrients in the promotion of healthspan: a new perspective' by Emma F. Jacquier, Amira Kassis, Diana Marcu, Nikhat Contractor, Jina Hong, Chun Hu, Marissa Kuehn, Christopher Lenderink, Arun Rajgopal; Frontiers 2024

Learning from the blue zones

However, there is much to suggest that our healthspan depends on a variety of factors, not just on our genetic make-up. As the medical journal 'The Lancet' recently noted in an article on longevity, scientists have found evidence of a complex interplay between genes and the environment in which humans operate.

In this context, research into the so-called Blue Zones has provided interesting insights. These are regions of the world that are characterized by a particularly high proportion of people aged 100 and over (centenarians). There are certainly genetic determinants of long life. In the blue zones such as Japan, for example, DNA combinations have been identified that are thought to promote longevity. At the same time, the dominant lifestyle of people in these zones is said to have at least as high of an an effect: a healthy diet, an active lifestyle and a lively social life, as well as comparatively low stress. The latter two factors can also be beneficial for mental health.

What matters most?

So, what is the key factor? Genes, social environment, modern medicine - or ultimately the individual behaviour? The American health consultancy Goinvo has combed through studies and tried to rank the hypothesized influences. According to this list, how someone sleeps, whether and how often they smoke or exercise contributes 36% to overall health. Social circumstances are also important, accounting for 24%. Genetic and biological influences account for 22% - and medical care for only 11%.

Such information could also be useful to investors interested in the investment theme of healthy longevity. However, not all health factors are equally accessible from an investor's perspective. Social health, for example, is still underrepresented in financial markets, while the healthcare sector is well established and continues to offer great investment opportunities, as recently discussed.

Healthy eating and nutritional supplements are also in the spotlight. Excessive consumption of fats, refined sugars and artificial additives are seen as a triggersfor disease. Also, excessive consumption of animal proteins, especially of red meat, as is common in many industrialized countries, is increasingly considered as being a negative contributor to a longer healthspan. Interestingly, demand for organically produced food is also growing in these regions. This is something that organic supermarket chains such as Sprouts Farmers Market can benefit from. With over 300 stores in the US, the company is one of the top three retailers in the world in this segment.

From wrinkles to Alzheimer's

The consumption of dietary supplements is also on the rise, especially in developed countries. While their efficaciousness is questioned by scientists, people hope they would prevent a wide range of ailments and signs of ageing, from wrinkles and hair loss to declining mobility and even Alzheimer's disease. According to a study by consulting firm SPINS, nearly 80% of consumers over the age of 55 in the US already take such supplements.

As long as they do little harm when used as labeled and meet stringent manufacturing specifications, authorities have so far placed few restrictions on their commercialization. Specialist companies such as the UK-based Haleon have already established themselves in this growth market - it is worth noting that Haleon was formed by the merger of divisions of the international pharmaceutical giants GSK and Pfizer.

Finally, active lifestyle service providers offer a wide range of investment opportunities. The outdoor and sports equipment on offer is by no means exclusively aimed at an older clientele. This again points to the long-term nature of the investment theme. This is evident, for example, in the case of Swiss clothing and running shoe manufacturer On, which now counts the US across all age demographics as its largest sales market. But it also brings to mind the 'Silver Economy', which caters more to older consumers, such as wellness providers, hotels, restaurants and travel. To this end, the company OneSpaWorld, which is by far the leading wellness service provider for cruises and increasingly for resorts, promises to be a long-term structural winner.

Active and diversified investment

It is clear that the concept of healthy ageing is far from being fully understood, and investing in the various health factors requires a great deal of expertise. Accordingly, actively managed investment strategies with diversified investments can be used to exploit the presumed potential. The Asset Management of Zürcher Kantonalbank, for example, focuses on several sub-areas of the 'Swisscanto (LU) Equity Fund Healthy Longevity' that may be of interest in terms of healthy life expectancy: healthy lifestyle, healthcare and silver economy products and services.

Investment theme «Healthy Longevity»: Insights

0%
Portfolio Manager Chi Tran-Brändli with insights about the theme of healthy longevity and it's investment opportunities.

Legal Disclaimer Switzerland and international

This document only serves advertising and information purposes, is for distribution in Switzerland only and is not directed at persons in whose nationality or place of residence prohibit access to such information under applicable law. Where not indicated otherwise, the information concerns the collective investment schemes under the law of Luxembourg managed by Swisscanto Asset Management International S.A. (hereinafter "Swisscanto Funds"). The products described are undertakings for collective investment in transferable securities (UCITS) within the meaning of EU Directive 2009/65/EC, which is governed by Luxembourg law and subject to the supervision of the Luxembourg supervisory authority (CSSF). This document does not constitute a solicitation or invitation to subscribe or make an offer to purchase any securities, nor does it form the basis of any contract or obligation of any kind. The sole binding basis for the acquisition of Swisscanto Funds are the respective legal documents (management regulations, sales prospectuses and key information documents (PRIIP KID), as well as financial reports), which can be obtained free of charge at https://products.swisscanto.com as well as at Swisscanto Fondsleitung AG, Bahnhofstrasse 9, CH-8001 Zurich (also acting as representative of the Luxembourg Swisscanto funds in Switzerland) or in all offices of Zürcher Kantonalbank. Paying Agent for the Luxembourg Swisscanto funds in Switzerland is Zürcher Kantonalbank, Bahnhofstrasse 9, CH-8001 Zurich. Information about the sustainability-relevant aspects in accordance with the Regulation (EU) 2019/2088 as well as Swisscanto's strategy for the promotion of sustainability and the pursuit of sustainability goals in the fund investment process are available on the same website. The sub-fund referred to in the document is subject to Article 9 of Regulation (EU) 2019/2088. The distribution of the fund may be suspended at any time. Investors will be informed about the deregistration in due time. The investment involves risks, in particular those of fluctuations in value and earnings. Investments in foreign currencies are subject to exchange rate fluctuations. Past performance is neither an indicator nor a guarantee of future success. The risks are described in the sales prospectus and in the PRIIP KID. The information contained in this document has been compiled with the greatest care. Despite professional procedures, the correctness, completeness and topicality of the information cannot be guaranteed. Any liability for investments based on this document will be rejected. The document does not release the recipient from his or her own judgment. In particular, the recipient is recommended to check the information for compatibility with his or her personal circumstances as well as for legal, tax and other consequences, if necessary, with the help of an advisor. The prospectus and PRIIP KID should be read before making any final investment decision. The products and services described in this document are not available to U.S. persons under the relevant regulations (in particular Regulation S under the U.S. Securities Act of 1933).

Data as at (where not stated otherwise): 11.2024

© Zürcher Kantonalbank. All rights reserved.
 

This document only serves advertising and information purposes and is not directed at persons in whose nationality or place of residence prohibit access to such information under applicable law. Where not indicated otherwise, the information concerns the collective investment schemes under the law of Luxembourg managed by Swisscanto Asset Management International S.A. (hereinafter "Swisscanto Funds"). The products described are undertakings for collective investment in transferable securities (UCITS) within the meaning of EU Directive 2009/65/EC, which is governed by Luxembourg law and subject to the supervision of the Luxembourg supervisory authority (CSSF).

This document does not constitute a solicitation or invitation to subscribe or make an offer to purchase any securities, nor does it form the basis of any contract or obligation of any kind. The sole binding basis for the acquisition of Swisscanto Funds are the respective published legal documents (management regulations, sales prospectuses and key information documents (PRIIP KID), as well as financial reports), which can be obtained free of charge at https://products.swisscanto.com/. Information about the sustainability-relevant aspects in accordance with the Regulation (EU) 2019/2088 as well as Swisscanto's strategy for the promotion of sustainability and the pursuit of sustainability goals in the fund investment process are available on the same website. The sub-fund referred to in the document is subject to Article 9 of Regulation (EU) 2019/2088.

The distribution of the fund may be suspended at any time. Investors will be informed about the deregistration in due time. The investment involves risks, in particular those of fluctuations in value and earnings. Investments in foreign currencies are subject to exchange rate fluctuations. Past performance is neither an indicator nor a guarantee of future success. The risks are described in the sales prospectus and in the PRIIP KID. The information contained in this document has been compiled with the greatest care. Despite professional procedures, the correctness, completeness and topicality of the information cannot be guaranteed. Any liability for investments based on this document will be rejected. The document does not release the recipient from his or her own judgment. In particular, the recipient is recommended to check the information for compatibility with his or her personal circumstances as well as for legal, tax and other consequences, if necessary, with the help of an advisor. The prospectus and PRIIP KID should be read before making any final investment decision.

An overview of investors' rights is available at https://www.swisscanto.com/int/en/legal/summary-of-investor-rights.html.

The products and services described in this document are not available to U.S. persons under the relevant regulations (in particular Regulation S under the U.S. Securities Act of 1933). Data as at (where not stated otherwise): 11.2024

© Zürcher Kantonalbank. All rights reserved.